Champions Oncology, Inc.
CSBR
$8.85
$0.242.79%
| Weiss Ratings | CSBR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | CSBR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CSBR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.33 | |||
| Price History | CSBR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -9.69% | |||
| 30-Day Total Return | -18.06% | |||
| 60-Day Total Return | -9.14% | |||
| 90-Day Total Return | 94.51% | |||
| Year to Date Total Return | 7.93% | |||
| 1-Year Total Return | 74.56% | |||
| 2-Year Total Return | 115.19% | |||
| 3-Year Total Return | 9.53% | |||
| 5-Year Total Return | 30.92% | |||
| 52-Week High % Change | -28.19% | |||
| 52-Week Low % Change | 139.16% | |||
| Price | CSBR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $11.99 | |||
| 52-Week Low Price | $3.60 | |||
| 52-Week Low Price (Date) | Sep 10, 2024 | |||
| 52-Week High Price (Date) | Jan 28, 2025 | |||
| Valuation | CSBR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 118.01M | |||
| Enterprise Value | 121.25M | |||
| Price/Earnings (TTM) | 19.48 | |||
| Earnings Per Share (TTM) | 0.44 | |||
| Earnings Per Share Growth | -160.77% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.11 | |||
| Price/Book (Q) | 21.58 | |||
| Enterprise Value/Revenue (TTM) | 2.07 | |||
| Price | $8.85 | |||
| Enterprise Value/EBITDA (TTM) | 14.39 | |||
| Enterprise Value/EBIT | 18.03 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | CSBR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 14.36M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CSBR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 201 808 8400 | |||
| Address | One University Plaza Hackensack, NJ 07601 | |||
| Website | www.championsoncology.com | |||
| Country | United States | |||
| Year Founded | 1985 | |||
| Profitability | CSBR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 11.47% | |||
| Profit Margin | 10.96% | |||
| Management Effectiveness | CSBR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 14.64% | |||
| Return on Equity | 376.84% | |||
| Income Statement | CSBR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 58.59M | |||
| Total Revenue (TTM) | 58.59M | |||
| Revenue Per Share | $4.08 | |||
| Gross Profit (TTM) | 30.22M | |||
| EBITDA (TTM) | 8.43M | |||
| EBIT (TTM) | 6.72M | |||
| Net Income (TTM) | 6.43M | |||
| Net Income Avl. to Common (TTM) | 6.43M | |||
| Total Revenue Growth (Q YOY) | 41.77% | |||
| Earnings Growth (Q YOY) | 277.67% | |||
| EPS Diluted (TTM) | 0.44 | |||
| EPS Diluted Growth (Q YOY) | 263.16% | |||
| Balance Sheet | CSBR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.20M | |||
| Cash Per Share (Q) | $0.22 | |||
| Total Current Assets (Q) | 19.70M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 5.47M | |||
| Current Ratio (Q) | 0.991 | |||
| Book Value Per Share (Q) | $0.40 | |||
| Total Assets (Q) | 30.63M | |||
| Total Current Liabilities (Q) | 19.87M | |||
| Total Debt (Q) | 6.44M | |||
| Total Liabilities (Q) | 25.16M | |||
| Total Common Equity (Q) | 5.47M | |||
| Cash Flow | CSBR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -25.00K | |||
| Cash from Financing (TTM) | 57.00K | |||
| Net Change in Cash (TTM) | -1.27M | |||
| Levered Free Cash Flow (TTM) | -3.34M | |||
| Cash from Operations (TTM) | -1.30M | |||
